Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19–Associated Hospitalizations Among Immunocompromised Adults — Nine States, January–September 2021

Effect of Immunosuppression on the Immunogenicity of mRNA Vaccines to SARS-CoV-2

(2021) Parakkal Deepak et al.   ANNALS OF INTERNAL MEDICINE

Effectiveness of Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccines for Preventing Coronavirus Disease 2019 Hospitalizations in the United States

(2021) Mark W Tenforde et al.   CLINICAL INFECTIOUS DISEASES

Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care Settings

(2021) Mark G. Thompson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Interim Estimates of COVID-19 Vaccine Effectiveness Against COVID-19–Associated Emergency Department or Urgent Care Clinic Encounters and Hospitalizations Among Adults During SARS-CoV-2 B.1.617.2 (Delta) Variant Predominance — Nine States, June–August 2021

(2021) Shaun J. Grannis et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Factors associated with COVID-19-related death using OpenSAFELY

(2020) Elizabeth J. Williamson et al.   NATURE

Effectiveness of Influenza Vaccine for Preventing Laboratory-Confirmed Influenza Hospitalizations in Immunocompromised Adults

(2020) Kailey Hughes et al.   CLINICAL INFECTIOUS DISEASES

Prevalence of Immunosuppression Among US Adults, 2013

(2016) Rafael Harpaz et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION